Serum anti-Mullerian hormone throughout the human menstrual cycle.
about
Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve MarkersRole of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a reviewIs AMH a regulator of follicular atresia?AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysisExperimental induction of reduced ovarian reserve in a nonhuman primate model (Macaca fascicularis)Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic reviewLuteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight womenDoes accelerated reproductive aging underlie premenopausal risk for cardiovascular disease?Impact of breast cancer on anti-mullerian hormone levels in young womenAnti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundabilityA pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancerAnti-Müllerian hormone deficiency in females with Fanconi anemia.Assay reproducibility and within-person variation of Müllerian inhibiting substance.Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women.Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles.Management of poor responders in IVF: is there anything new?In vivo fate mapping of cryopreserved murine ovarian grafts.Anti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization.Regulation of anti-Müllerian hormone production in the cow: a multiscale study at endocrine, ovarian, follicular, and granulosa cell levels.Prediction of assisted reproductive technique outcome in elevated early follicular phase follicle stimulating hormone with Mullerian inhibiting substance levelOvarian function in Duarte galactosemiaClinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHHSerum antimüllerian hormone measurements with second generation assay at two distinct menstrual cycle phases for prediction of cycle cancellation, pregnancy and live birth after in vitro fertilization.The role of anti-Müllerian hormone in female fertility and infertility - an overview.The physiology and clinical utility of anti-Mullerian hormone in women.Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?Variations in serum müllerian inhibiting substance between white, black, and Hispanic women.The impact of endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum anti-Mullerian hormone: a prospective cohort studyLack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome.Prediction of reproductive outcomes according to different serum anti-Müllerian hormone levels in females undergoing intracystoplasmic sperm injectionReduced serum levels of anti-Müllerian hormone in females with inherited bone marrow failure syndromesFertility preservation and breast cancer: a reviewIntra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriersAnti-Mullerian hormone levels decline under hormonal suppression: a prospective analysis in fertile women after delivery.Serum antimüllerian hormone in healthy premenopausal women.Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile(49)Ser) and Anti-Müllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology.Bivariate analysis of basal serum anti-Müllerian hormone measurements and human blastocyst development after IVF.Different ovarian response by age in an anti-Müllerian hormone-matched group undergoing in vitro fertilization.Ovarian reserve testsWhat is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?
P2860
Q26765770-7002066C-85C5-4921-9709-B25B53ED373FQ26774060-C8C29349-B54B-46D0-AE26-396CBEC4E7C8Q27006736-B8FA645C-3FA2-424E-83B6-410E3BCC98C3Q28289118-4C0A9C36-E6A2-4E69-ABBE-2121A2F153CAQ28384069-A2C0F1BF-112C-4F4C-B2E5-570D4197D982Q28384104-D2264042-B203-4B5B-89CB-01004BB60F13Q28391267-56BC8F86-EA24-4BA9-AE44-B9740C85C589Q28391817-DFB01280-A478-4941-B58C-81CF39E618CCQ28392860-86773E9D-7DB9-4F05-B6BF-AFB3EC168366Q28396276-D8433FCF-002E-41EA-B46B-C6385D905A41Q30435881-D8C046FC-47CC-4350-B31E-A5F0C878A453Q33569005-A1F86CDA-CC10-490F-A417-7835659CD0F3Q33875907-A60F890F-EA3C-43A7-A85C-C0804C15B77BQ33888297-EBCA6505-9A3C-4B0D-ABB6-851453686AC1Q33937262-17865D11-A6C9-457D-83DF-18935DA5422FQ34022512-5345EA10-B4ED-4BA2-9807-8B79854C493CQ34091382-BD5BCE7F-29CA-4339-BEA7-B36A4AF1687BQ34138075-550B0D97-99E9-4B69-9DA0-6EE423C37357Q34149740-518AC8D8-8737-4602-8FE3-3566BA2F2AF3Q34196639-84A1F98D-52A0-418C-8E53-B4E76CB99F9CQ34196652-E09993E8-B60A-485D-A47A-5541FCAF654EQ34226336-A0E9F1C3-1C3E-447A-BA6D-2E20C985ACC8Q34226385-21F2FCF6-98CE-4708-AA52-0400422EE89DQ34278051-FD7B45F1-4960-41D5-ABD9-A26DF54CE4DDQ34398233-3AAE6AD9-22CD-4C70-B91A-706824F86886Q34415976-1C2BEA77-7B74-4681-81E4-4746430A6B4BQ34568747-1F9E1170-92B5-4D49-B0BC-F9C4C8415351Q34631101-E4DB6CCB-EA5B-4954-97BA-5BF73A22EA44Q34810982-40A3F821-628B-4772-B890-413947425DFEQ34999705-F3C25464-DC55-40E5-BEC7-DBAD59D19FA1Q35055118-72E832E0-EB3E-4DA7-B62C-A7649CF7920BQ35106163-C839883E-41E1-4B20-B686-596ACC223EDEQ35108269-3FDE2F1B-B0B9-4573-BD5A-384BCF9267C5Q35158333-D3D654A1-7007-4EE1-AD6E-3272292DBF8BQ35185385-AB11F989-191B-4830-A147-6FB06E10BF34Q35186943-170B12B2-17E8-4B18-BBA0-90A0F1FDC698Q35620057-FA2E41D0-1AFE-4FAF-A5C8-F7D6892A6840Q35722615-F48914DD-63C1-493C-8AAD-2AEC5D5118CDQ35749173-78F958A5-6423-4DE3-AEE5-549E8018A38EQ35750252-B91F4EDE-F81D-4C63-935F-91611E4F47A3
P2860
Serum anti-Mullerian hormone throughout the human menstrual cycle.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Serum anti-Mullerian hormone throughout the human menstrual cycle.
@en
Serum anti-Mullerian hormone throughout the human menstrual cycle.
@nl
type
label
Serum anti-Mullerian hormone throughout the human menstrual cycle.
@en
Serum anti-Mullerian hormone throughout the human menstrual cycle.
@nl
prefLabel
Serum anti-Mullerian hormone throughout the human menstrual cycle.
@en
Serum anti-Mullerian hormone throughout the human menstrual cycle.
@nl
P2093
P2860
P356
P1433
P1476
Serum anti-Mullerian hormone throughout the human menstrual cycle.
@en
P2093
A Carducci Artenisio
P2860
P304
P356
10.1093/HUMREP/DEL291
P407
P577
2006-08-21T00:00:00Z